Literature DB >> 21939468

Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.

F Kontopidou1, D Plachouras, E Papadomichelakis, G Koukos, I Galani, G Poulakou, G Dimopoulos, A Antoniadou, A Armaganidis, H Giamarellou.   

Abstract

In recent years there has been renewed interest in colistin for the treatment of infections by multidrug-resistant Gram-negative bacteria, causing concern that increasing use may be accompanied by the emergence of resistance. This is a retrospective cohort study of colonization and infection by colistin-resistant (CR) gram-negative bacteria in critically ill patients. Colonization data were based on surveillance culture results. Among 150 patients, 78 (52%) were colonized by CR Gram-negative bacteria. Among them, 30 (20%) were colonized by Klebsiella pneumoniae isolates and 51 (34%) were colonized by intrinsically resistant to colistin (CIR) enterobacteriaceae. Seven cases of infection were caused by CR K. pneumoniae and 12 cases by CIR strains. The main risk factor for colonization by CR pathogens was colistin treatment.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21939468     DOI: 10.1111/j.1469-0691.2011.03649.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  32 in total

1.  Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.

Authors:  Helen Giamarellou; Lambrini Galani; Fotini Baziaka; Ilias Karaiskos
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

Review 2.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

3.  mgrB Mutations Mediating Polymyxin B Resistance in Klebsiella pneumoniae Isolates from Rectal Surveillance Swabs in Brazil.

Authors:  Caio Augusto Martins Aires; Polyana Silva Pereira; Marise Dutra Asensi; Ana Paula D'Alincourt Carvalho-Assef
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

4.  Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?

Authors:  Nenad Macesic; Brian Nelson; Anne-Catrin Uhlemann
Journal:  Clin Infect Dis       Date:  2017-08-15       Impact factor: 9.079

5.  XDR-Klebsiella pneumoniae isolates harboring blaOXA-48: In vitro and in vivo evaluation using a murine thigh-infection model.

Authors:  Noha A Kamel; Wafaa N El-Tayeb; Mona R El-Ansary; Mohamed T Mansour; Khaled M Aboshanab
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-31

Review 6.  Insights into Newer Antimicrobial Agents Against Gram-negative Bacteria.

Authors:  Neelam Taneja; Harsimran Kaur
Journal:  Microbiol Insights       Date:  2016-03-20

7.  Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen.

Authors:  J P Mills; M B Wilck; B C Weikert; P M Porrett; D Timko; K Alby; R A Bonomo; E A Blumberg
Journal:  Transpl Infect Dis       Date:  2016-09-07       Impact factor: 2.228

8.  The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients.

Authors:  M Papadimitriou-Olivgeris; M Christofidou; F Fligou; C Bartzavali; T Vrettos; K S Filos; M Marangos; E D Anastassiou
Journal:  Infection       Date:  2014-07-10       Impact factor: 3.553

9.  Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience.

Authors:  Balaji Veeraraghavan; Chaitra Shankar; Susmitha Karunasree; Shantha Kumari; Raji Ravi; Ravikar Ralph
Journal:  Pathog Glob Health       Date:  2017-07-02       Impact factor: 2.894

10.  Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria.

Authors:  Nicola Petrosillo; Maddalena Giannella; Massimo Antonelli; Mario Antonini; Bruno Barsic; Laura Belancic; Cagkan Inkaya A; Gennaro De Pascale; Elisabetta Grilli; Mario Tumbarello; Murat Akova
Journal:  Antimicrob Agents Chemother       Date:  2013-11-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.